Genetic Leukodystrophies Mimicking CNS Inflammation - Part 2

Genetic Leukodystrophies Mimicking CNS Inflam...

Up next

Resolution of PML after Treatment with Virus-Specific T Cells and HCT

Dr. Justin Abbatemarco talks with Dr. Irene Cortese about recent advances in the treatment of progressive multifocal leukoencephalopathy (PML), focusing on immune-based therapies like virus-specific T cells and immune checkpoint inhibitors. Read the related article in The New Eng ...  Show more

Primary Motor Cortex Involvement and Seizure Risk in Patients With Brain Metastases

Dr. Kait Nevel talks with Drs. Ayal Aizer and Clara Baselga-Garriga about the link between primary motor cortex involvement in brain metastases and increased seizure risk, highlighting implications for patient management and future research directions. Read the related article in ...  Show more

Recommended Episodes

Long-Term Outcomes and Rehabilitation in Anti-NMDAR Encephalitis - Part 2
Neurology Minute

In part two of this two-part series, Dr. Justin Abbatemarco and Dr. Maarten Titulaer discuss the link between HSV and NMDAR encephalitis and how that impacts longitudinal recovery. Show reference:  https://www.neurology.org/doi/pdf/10.1212/WNL.0000000000210109 

Consensus Recommendations for the Management of Neurosarcoidosis - Part 2
Neurology Minute

In part two of this series, Dr. Shuvro Roy and Dr. Giovanna S. Manzano discuss the main findings from her study on neurosarcoidosis. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200429    

IGLON5 Frequency in Idiopathic REM Sleep Behavior Disorder - Part 2
Neurology Minute

In part two of this two-part series, Dr. Jeff Ratliff and Dr. Ron Postuma discuss how clinicians should approach serological antibody testing in patients with REM behavior disorder or other associated neurologic symptoms. Show reference: https://www.neurology.org/doi/10.1212/NXI. ...  Show more

Incorporating Genetic Testing Into the Care of Patients with ALS/FTD
Neurology Minute

Dr. Gordon Smith talks with Laynie Dratch about integrating genetic testing into patient care for persons with Amyotrophic lateral sclerosis (ALS) and frontotemporal degeneration (FTD) spectrum disorders.